SCHEMBL27008503

SCHEMBL27008503

Cc1cc([C@@H](C)NC(=O)O)c2oc(-c3ccccc3)cc(=O)c2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 10/20 0.65
▸ PIK3CB P42338 3/20 0.65
▸ PIK3CD O00329 2/20 0.65
▸ PIK3CG P48736 2/20 0.65
▸ CSNK2A2 P19784 4/20 0.49
▸ CSNK2B P67870 4/20 0.49
▸ CSNK2A1 P68400 4/20 0.49
▸ TP53 P04637 3/20 0.49
▸ CYP3A4 P08684 3/20 0.49
▸ MAPT P10636 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ PRKDC P78527 2/20 0.47
▸ MTOR P42345 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27132077 1.00 PIK3CA (0.65) PIK3CAPIK3CBPIK3CDPIK3CGCSNK2A2
SCHEMBL27008382 0.88 PIK3CA (0.60) PIK3CAPIK3CBPIK3CDPIK3CGCSNK2A2
SCHEMBL27129875 0.88 PIK3CA (0.60) PIK3CAPIK3CBPIK3CDPIK3CGCSNK2A2
SCHEMBL26881677 0.87 PIK3CA (0.56) PIK3CAPIK3CBPIK3CDPIK3CGCSNK2A2
SCHEMBL24912684 0.85 PIK3CD (0.60) PIK3CAPIK3CBPIK3CDPIK3CGCSNK2A2
SCHEMBL27008375 0.85 PIK3CA (0.56) PIK3CAPIK3CBPIK3CDPIK3CGMAPT
SCHEMBL27132354 0.85 PIK3CA (0.56) PIK3CAPIK3CBPIK3CDPIK3CGMAPT
SCHEMBL24912818 0.84 PIK3CA (0.72) PIK3CAPIK3CBPIK3CDPIK3CGPRKDC
SCHEMBL24912829 0.84 PIK3CA (0.72) PIK3CAPIK3CBPIK3CDPIK3CGPRKDC
SCHEMBL27130492 0.84 PIK3CA (0.50) PIK3CAPIK3CBPIK3CDPIK3CGCSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE LOXO ONCOLOGY, INC. 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PIK3CA, PIK3R4, PIK3R5 PIK3CA 1/4885PIK3CB 16/4885PIK3CD 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback